PR PolyResearch

Join Free

NASDAQ

Synopsys, Inc. (SNPS)

♥ 591 Thanks from members

Synopsys, Inc. (SNPS) faces a significant market divergence as a 21% three-month stock decline contrasts with raised fiscal 2026 guidance, driven by high investor expectations, AI-driven opportunity costs, and lagging alternative data signals like open job postings.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Superior Group of Companies, Inc. (SGC)

AbCellera Biologics Inc. - Common Shares (ABCL)

Alpha Blue Capital US Small-Mid Cap Dynamic ETF (ABCS)